These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17515643)

  • 1. Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.
    Fujisaki S; Fujisaki S; Ibe S; Asagi T; Itoh T; Yoshida S; Koike T; Oie M; Konda M; Sadamasu K; Nagashima M; Gatanaga H; Matsuda M; Ueda M; Masakane A; Hata M; Mizogami Y; Mori H; Minami R; Okada K; Watanabe K; Shirasaka T; Oka S; Sugiura W; Kaneda T
    Jpn J Infect Dis; 2007 May; 60(2-3):113-7. PubMed ID: 17515643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
    Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
    J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.
    De Luca A; Cozzi-Lepri A; Perno CF; Balotta C; Di Giambenedetto S; Poggio A; Pagano G; Tositti G; Piscopo R; Del Forno A; Chiodo F; Magnani G; d'Arminio Monforte A; ;
    Antivir Ther; 2004 Oct; 9(5):743-52. PubMed ID: 15535412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 antiretroviral resistance testing laboratories.
    Hofherr LK; Francis DP; Astles JR; Schalla WO
    Clin Lab Sci; 2002; 15(4):213-9. PubMed ID: 12776781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to protease inhibitors.
    Kuritzkes DR
    J HIV Ther; 2002 Nov; 7(4):87-91. PubMed ID: 12733606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
    Verhofstede C; Van Wanzeele F; Van Der Gucht B; Pelgrom J; Vandekerckhove L; Plum J; Vogelaers D
    J Med Virol; 2007 Sep; 79(9):1254-60. PubMed ID: 17607772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance in variants from the female genital tract and plasma.
    Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
    J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genotypic resistance testing on physician selection of antiretroviral therapy.
    Jones S; Klotman ME
    J Hum Virol; 2001; 4(4):214-6. PubMed ID: 11694849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.
    Liuzzi G
    Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.
    Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J
    J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
    Vercauteren J; Vandamme AM
    Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy.
    Macias J; Palomares JC; Mira JA; Torres MJ; García-García JA; Rodríquez JM; Vergera S; Pineda JA
    J Infect; 2005 Oct; 51(3):195-200. PubMed ID: 16230215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genotypic resistance in HIV-1-infected patients with persistent low-level viremia].
    Parra-Ruiz J; Alvarez M; Chueca N; Peña A; Pasquau J; López-Ruz MA; Maroto Mdel C; Hernández-Quero J; García F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):75-80. PubMed ID: 19254638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand.
    Poonpiriya V; Sungkanuparph S; Leechanachai P; Pasomsub E; Watitpun C; Chunhakan S; Chantratita W
    J Virol Methods; 2008 Jul; 151(1):79-86. PubMed ID: 18462814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme.
    Pandit A; Mackay WG; Steel C; van Loon AM; Schuurman R
    J Clin Virol; 2008 Dec; 43(4):401-6. PubMed ID: 18977690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
    J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
    AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.